Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant virus encoding one or more heterologous proteins...
Reexamination Certificate
2007-03-20
2007-03-20
Chen, Stacy B. (Department: 1648)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant virus encoding one or more heterologous proteins...
C424S211100, C435S069100, C536S023720
Reexamination Certificate
active
09733692
ABSTRACT:
Chimeric parainfluenza viruses (PIVs) incorporate a PIV vector genome or antigenome and one or more antigenic determinant(s) of a heterologous PIV or non-PIV pathogen. These chimeric viruses are infectious and attenuated in humans and other mammals and are useful in vaccine formulations for eliciting an immune responses against one or more PIVs, or against a PIV and non-PIV pathogen. Also provided are isolated polynucleotide molecules and vectors incorporating a chimeric Ply genome or antigenome which includes a partial or complete PIV vector genome or antigenome combined or integrated with one or more heterologous gene(s) or genome segment(s) encoding antigenic determinant(s) of a heterologous PIV or non-PIV pathogen.
REFERENCES:
patent: 5869036 (1999-02-01), Belshe et al.
patent: 5993824 (1999-11-01), Murphy et al.
patent: 6264957 (2001-07-01), Collins et al.
patent: 6410023 (2002-06-01), Durbin et al.
patent: 6689367 (2004-02-01), Collins et al.
patent: 6699476 (2004-03-01), Collins et al.
patent: 702 085 (1996-03-01), None
patent: WO 93/14207 (1993-07-01), None
patent: WO 97/06270 (1997-02-01), None
patent: WO 98/02530 (1998-01-01), None
patent: WO 98/53078 (1998-01-01), None
patent: WO/00/061737 (2000-10-01), None
patent: WO 01/04320 (2001-01-01), None
Barouch et al, Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes, Nature 415:335-339, Jan. 17, 2002.
Walker et al, “Escape from the immune system”, Nature 407:313-314, Sep. 21, 2000.
Anderson et al.,J. Infect. Dis. 151:626-633, 1985.
Bailly et al.,J. Virol. 74:3188-3195, 2000.
Bailly et al.,Virus Genes20:173-82, 2000.
Baron et al.,J. Virol. 71:1265-1271, 1997.
Beeler et al.,J. Virol. 63:2941-2950, 1989.
Bellanti,Pediatrics48:715-29, 1971.
Belshe et al.,Infect. Immun. 37:160-5, 1982.
Belshe & Hissom,J. Med. Virol. 10:235-42, 1982.
Belshe et al.,N. Engl. J. Med. 338:1405-1412, 1998.
Black & Sheridan,N. Engl. J. Med. 263:165-169, 1960.
Blanchard et al.,J. Gen. Virol. 79:1159-1167, 1998.
Bousse et al.,Virology204:506-14, 1994.
Bray & Lai,Proc. Natl. Acad. Sci. USA88:10342-6, 1991.
Bucholz et al.J. Virol. 73:251-259, 1999.
Bukreyev et al.,J. Virol. 70:6634-41, 1996.
Bukreyev et al.,Proc. Natl. Acad. Sci. USA96:2367-72, 1999.
Buser,N. Engl. J. Med. 277:250-1, 1967.
Calain & Ruox,J. Virol. 67:4822-30, 1993.
Carroll & Moss,Virology238:198-211, 1997.
Chen et al.,J. Infect. Dis. 162:1036-42, 1990.
Cheng et al.,Proc. Natl. Acad. Sci. USA91:5695-5699, 1994.
Clements et al.,J. Clin. Microbiol. 29:1175-82, 1991.
Coates et al.,Am. J. Epidemiol. 83:299-313, 1966.
Coelingh et al.,Virology162:137-143, 1988.
Collins et al., 3rd ed. In “Fields Virology,” B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Straus, Eds., vol. 1, pp. 1205-1243. Lippincott-Raven Publishers, Philadelphia, 1996.
Collins et al.,Proc. Natl. Acad. Sci. USA92:11563-11567, 1995.
Conzelmann,J. Gen. Virol. 77:381-89, 1996.
Corsaro and Pearson,Somatic Cell Genetics7:603-616, 1981.
Crookshanks & Belshe,J. Med. Virol. 13:243-9, 1984.
Crowe,Vaccine13:415-421, 1995.
Cutts et al.,Biologicals25:323-38, 1997.
Deng et al.,Arch. Virol. Suppl. 13:115-30, 1997.
Deng et al.,Virology209:457-69, 1995.
Deng, et al.,Virology253:43-54, 1999.
Dimock & Collins,J. Virol. 67: 2772-8, 1993.
Drexler et al.,J. Gen. Virol. 79:347-352, 1998.
Drillien et al.,Proc. Natl. Acad. Sci. USA85:1252-6, 1988.
Durbin et al.,J. Infect. Dis. 179:1345-51, 1999.
Durbin et al.,Vaccine16:1324-30, 1998.
Durbin et al.,Virology235:323-332, 1997.
Durbin et al.,Virology261:319-30, 1999.
Durbin et al.,Virology234:74-83, 1997.
Durbin et al.,J. Virol. 74:6821-31, 2000.
Elango et al.,J. Virol. 57:481-489, 1986.
Fenner et al.,Scand. J. Immunol. 24:341-349, 1986.
Fernie et al.,Proc. Soc. Exp. Biol. Med. 171:266-271, 1982.
Finke & Cozelmann,J. Virol. 71:7281-8, 1997.
Fooks et al.,J. Gen. Virol. 79:1027-31, 1998.
Fulginiti et al.,JAMA202:1075-80, 1967.
Galinski et al.,Virology165: 499-510, 1988.
Galinski M. S. In Kingsbury, D. W. (Ed.),The Paramyxoviruses, pp. 537-568, Plenum Press, New York, 1991.
Galletti et al.,Vaccine13:197-201,1995.
Garcin et al.,EMBO J. 14:6087-6094, 1995.
Gellin & Katz,J. Infect. Dis. 170:S3-14, 1994.
Graham and Van der Eb,Virology52:456-467, 1973.
Grosfeld et al.,J. Virol. 69:5677-5686, 1995.
Guirakhoo et al.,Virology257:363-72, 1999.
Haas et al.,Current Biol. 6:315-324, 1996.
Hall et al.,Virus Res. 22:173-184, 1992.
Halsey et al.,N. Engl. J. Med. 313:544-9, 1985.
Hasan et al.,J. Gen. Virol. 78:2813-20, 1997.
Hawley-Nelson et al.,Focus15:73-79, 1993.
He et al.,Virology237:249-60, 1997.
Heikkinen et al.,N. Engl. J. Med. 340:260-4, 1999.
Hoffman & Banerjee,J. Virol. 71:4272-4277, 1997.
Holt et al.,J. Infect. Dis. 168:1087-96, 1993.
Hummel & Bellini,J. Virol. 69:1913-6, 1995.
Jin et al.Virology251:206-214, 1998.
Johnson et al.,J. Virol. 71:5060-8, 1997.
Juhasz et al.,J. Virol. 71:5814-5819, 1997.
Kahn et al.,Virology254:81-91, 1999.
Karron et al.,J. Inf. Dis. 172:1445-1450, 1995.
Karron et al.,Pediatr. Infect. Dis. J. 14:10-16, 1995.
Karron et al.,Pediatr. Infect. Dis. J. 15:650-654, 1996.
Kato et al.,EMBO16:578-587, 1997.
Kato et al.,Genes to Cells1:569-579, 1996.
Kok,Trans. R. Soc. Trop. Med. Hyg. 77:171-6, 1983.
Kretschmer et al.,Virology216:309-316, 1996.
Kretzschmar et al.,J. Virol. 71:5982-9, 1997.
Kunkel et al.,Methods Enzymol. 154:367-382, 1987.
Lawson et al.,Proc. Natl. Acad. Sci. USA92:4477-81, 1995.
Markowitz et al.,N. Engl. J. Med. 322:580-7, 1990.
Marx et al.,J. Infect. Dis. 176:1423-1427, 1997.
Mayr et al.,Infection3:6-14, 1975.
Mayr et al.,Zentralbl. Bakteriol. [B] 167:375-90, 1978.
Mbiguino & Menezes,J. Virol. Methods31:161-170, 1991.
Mebatsion et al.,J. Virol. 69:1444-1451, 1995.
Mebatsion et al.,Proc. Natl. Acad. Sci. USA93:7310-4, 1996.
Men et al.,J. Virol.70:3930-7, 1996.
Meyer et al.,J. Gen. Virol.72:1031-1038, 1991.
Moriya et al.,FEBS Lett.425:105-11, 1998.
Murphy et al.,Infect. Immun.12:62-68, 1975.
Murphy,Infectious Diseases in Clinical Practice2:174-181, 1993.
Murphy et al.,J. Clin. Microbiol.24:894-8, 1986.
Murphy et al.,J. Virol.62:3907-10, 1988.
Murphy et al.,Virus Res.11 :1-15, 1988.
Nader et al.,J. Pediatr.72:22-8, 1968.
Needleman & Wunsch,J. Mol. Biol.48:443-453, 1970.
Neumann et al.,EMBO J.1:841-845, 1982.
Norrby & Gollman,Infect. Immun.11:231-9, 1975.
Norrby et al.,J. Infect. Dis.132:262-9, 1975.
Olmsted et al.,J. Virol.63:411-420, 1989.
Osterhaus et al.,Vaccine16:1479-81, 1998.
Palese et al.,Proc. Natl. Acad. Sci. USA93:11354-58, 1996.
Pearson & Lipman,Proc. Natl. Acad. Sci. USA85:2444-2448, 1988.
Perez-Schael et al.,N. Engl. J. Med.337:1181-7, 1997.
Perrotta & Been,Nature250:434-436, 1991.
Peeters et al.J. Virol.73:5001-5009, 1999.
Pletnev & Men,Proc. Natl. Acad. Sci. USA95:1746-51, 1998.
Polack et al.,Nat. Med.5:629-34, 1999.
Radecke et al.,EMBO J.14:5773-5784, 1995.
Radecke & Billeter,Virology217:418-421, 1996.
Rauh & Schmidt,Am. J. Dis. Child109:232-239, 1965.
Ray & Compans,Virology148:232-236, 1986.
Redfield et al.,N. Engl. J. Med.316:673-676, 1987.
Reed et al.,J. Infect. Dis.175:807-13, 1997.
Roberts et al.,J. Virol.72:4704-11, 1998.
Roberts et al.,J. Virol.73:3723-32, 1999.
Roberts & Rose,Virology247:1-6, 1998.
Roden et al.,J. Virol.70:5875-83, 1996.
Rydbeck et al.,J. Gen. Virol.67:1531-1542, 1986.
Rydbeck et al.,J. Gen. Virol.69:931-5, 1988.
Sabin et al.,J. Infect. Dis.152:1231-7, 1985.
Sakai et al.,FEBS Lett.456:221-226, 1999.
Sato et al.,J. Gen. Virol.66:1397-1409, 1985.
Schmidt et al.,J. Virol.74:8922-9, 2000.
Schneider et al.,Virology227:314-322, 1997.
Schnell et al.,Cell90:849-57, 1997.
Schnell et al.,EMBO J.13:4195-203, 1994.
Schnell et al.,J. Virol.70:2318-23, 1996.
Schnell et al.,Proc. Natl. Acad. Sci. USA93:11359-65, 1996.
Sheshberadaran et al.,Arch. Virol.83:251-68, 1985.
Siegrist & Lambert,Dev. Biol. Stand.95:133-9, 1998.
Siegrist et al.,Vaccine16:1409-14, 1998.
Simasathien et al.,Vaccine15:329-34, 1997.
Singh & Bill
Collins Peter L.
Durbin Anna P.
Murphy Brian R.
Schmidt Alexander C.
Skiadopoulos Mario H.
Chen Stacy B.
The United States of America, Represented by the Secretary, Depa
LandOfFree
Use of recombinant parainfluenza viruses (PIVs) as vectors... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of recombinant parainfluenza viruses (PIVs) as vectors..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of recombinant parainfluenza viruses (PIVs) as vectors... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3753815